Cargando…

Evaluating and Using Observational Evidence: The Contrasting Views of Policy Makers and Epidemiologists

BACKGROUND: Currently, little is known about the types of evidence used by policy makers. This study aimed to investigate how policy makers in the health domain use and evaluate evidence and how this differs from academic epidemiologists. By having a better understanding of how policy makers select,...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Donoughue Jenkins, Lily, Kelly, Paul M., Cherbuin, Nicolas, Anstey, Kaarin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138237/
https://www.ncbi.nlm.nih.gov/pubmed/27999772
http://dx.doi.org/10.3389/fpubh.2016.00267
_version_ 1782472029127049216
author O’Donoughue Jenkins, Lily
Kelly, Paul M.
Cherbuin, Nicolas
Anstey, Kaarin J.
author_facet O’Donoughue Jenkins, Lily
Kelly, Paul M.
Cherbuin, Nicolas
Anstey, Kaarin J.
author_sort O’Donoughue Jenkins, Lily
collection PubMed
description BACKGROUND: Currently, little is known about the types of evidence used by policy makers. This study aimed to investigate how policy makers in the health domain use and evaluate evidence and how this differs from academic epidemiologists. By having a better understanding of how policy makers select, evaluate, and use evidence, academics can tailor the way in which that evidence is produced, potentially leading to more effective knowledge translation. METHODS: An exploratory mixed-methods study design was used. Quantitative measures were collected via an anonymous online survey (n = 28), with sampling from three health-related government and non-government organizations. Semi-structured interviews with policy makers (n = 20) and epidemiologists (n = 6) were conducted to gather qualitative data. RESULTS: Policy makers indicated systematic reviews were the preferred research resource (19%), followed closely by qualitative research (16%). Neither policy makers nor epidemiologists used grading instruments to evaluate evidence. In the web survey, policy makers reported that consistency and strength of evidence (93%), the quality of data (93%), bias in the evidence (79%), and recency of evidence (79%) were the most important factors taken into consideration when evaluating the available evidence. The same results were found in the qualitative interviews. Epidemiologists focused on the methodology used in the study. The most cited barriers to using robust evidence, according to policy makers, were political considerations (60%), time limitations (55%), funding (50%), and research not being applicable to current policies (50%). CONCLUSION: The policy maker’s investigation did not report a systematic approach to evaluating evidence. Although there was some overlap between what policy makers and epidemiologists identified as high-quality evidence, there was also some important differences. This suggests that the best scientific evidence may not routinely be used in the development of policy. In essence, the policy-making process relied on other jurisdictions’ policies and the opinions of internal staff members as primary evidence sources to inform policy decisions. Findings of this study suggest that efforts should be directed toward making scientific information more systematically available to policy makers.
format Online
Article
Text
id pubmed-5138237
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-51382372016-12-20 Evaluating and Using Observational Evidence: The Contrasting Views of Policy Makers and Epidemiologists O’Donoughue Jenkins, Lily Kelly, Paul M. Cherbuin, Nicolas Anstey, Kaarin J. Front Public Health Public Health BACKGROUND: Currently, little is known about the types of evidence used by policy makers. This study aimed to investigate how policy makers in the health domain use and evaluate evidence and how this differs from academic epidemiologists. By having a better understanding of how policy makers select, evaluate, and use evidence, academics can tailor the way in which that evidence is produced, potentially leading to more effective knowledge translation. METHODS: An exploratory mixed-methods study design was used. Quantitative measures were collected via an anonymous online survey (n = 28), with sampling from three health-related government and non-government organizations. Semi-structured interviews with policy makers (n = 20) and epidemiologists (n = 6) were conducted to gather qualitative data. RESULTS: Policy makers indicated systematic reviews were the preferred research resource (19%), followed closely by qualitative research (16%). Neither policy makers nor epidemiologists used grading instruments to evaluate evidence. In the web survey, policy makers reported that consistency and strength of evidence (93%), the quality of data (93%), bias in the evidence (79%), and recency of evidence (79%) were the most important factors taken into consideration when evaluating the available evidence. The same results were found in the qualitative interviews. Epidemiologists focused on the methodology used in the study. The most cited barriers to using robust evidence, according to policy makers, were political considerations (60%), time limitations (55%), funding (50%), and research not being applicable to current policies (50%). CONCLUSION: The policy maker’s investigation did not report a systematic approach to evaluating evidence. Although there was some overlap between what policy makers and epidemiologists identified as high-quality evidence, there was also some important differences. This suggests that the best scientific evidence may not routinely be used in the development of policy. In essence, the policy-making process relied on other jurisdictions’ policies and the opinions of internal staff members as primary evidence sources to inform policy decisions. Findings of this study suggest that efforts should be directed toward making scientific information more systematically available to policy makers. Frontiers Media S.A. 2016-12-06 /pmc/articles/PMC5138237/ /pubmed/27999772 http://dx.doi.org/10.3389/fpubh.2016.00267 Text en Copyright © 2016 O’Donoughue Jenkins, Kelly, Cherbuin and Anstey. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
O’Donoughue Jenkins, Lily
Kelly, Paul M.
Cherbuin, Nicolas
Anstey, Kaarin J.
Evaluating and Using Observational Evidence: The Contrasting Views of Policy Makers and Epidemiologists
title Evaluating and Using Observational Evidence: The Contrasting Views of Policy Makers and Epidemiologists
title_full Evaluating and Using Observational Evidence: The Contrasting Views of Policy Makers and Epidemiologists
title_fullStr Evaluating and Using Observational Evidence: The Contrasting Views of Policy Makers and Epidemiologists
title_full_unstemmed Evaluating and Using Observational Evidence: The Contrasting Views of Policy Makers and Epidemiologists
title_short Evaluating and Using Observational Evidence: The Contrasting Views of Policy Makers and Epidemiologists
title_sort evaluating and using observational evidence: the contrasting views of policy makers and epidemiologists
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138237/
https://www.ncbi.nlm.nih.gov/pubmed/27999772
http://dx.doi.org/10.3389/fpubh.2016.00267
work_keys_str_mv AT odonoughuejenkinslily evaluatingandusingobservationalevidencethecontrastingviewsofpolicymakersandepidemiologists
AT kellypaulm evaluatingandusingobservationalevidencethecontrastingviewsofpolicymakersandepidemiologists
AT cherbuinnicolas evaluatingandusingobservationalevidencethecontrastingviewsofpolicymakersandepidemiologists
AT ansteykaarinj evaluatingandusingobservationalevidencethecontrastingviewsofpolicymakersandepidemiologists